Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jan 19, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Acumen Pharmaceuticals, Inc.
-8.93K
$3.48
-$31,048.43
-7.58%
108.87K
Jan 19
Scheduled
Acumen Pharmaceuticals, Inc.
91K
—
—
+339.55%
117.8K
Jan 2
Acumen Pharmaceuticals, Inc.
26.8K
—
—
∞
26.8K
Jan 17
Acumen Pharmaceuticals, Inc.
0
—
—
—
0
Sep 6
Acumen Pharmaceuticals, Inc.
0
—
—
—
0
X4 Pharmaceuticals, Inc
-8.33K
—
—
-5.43%
145.16K
Aug 17
Scheduled
X4 Pharmaceuticals, Inc
-4.17K
—
—
-2.64%
153.49K
Jun 24
Scheduled
X4 Pharmaceuticals, Inc
-4.17K
—
—
-2.57%
157.66K
Jun 16
Scheduled
X4 Pharmaceuticals, Inc
105K
—
—
+184.79%
161.82K
Mar 1
X4 Pharmaceuticals, Inc
-15.91K
—
—
-21.87%
56.82K
Feb 11
Scheduled
X4 Pharmaceuticals, Inc
-8.33K
$5.10
-$42,493.20
-10.28%
72.73K
Aug 17
Scheduled
X4 Pharmaceuticals, Inc
8.33K
$7.00
-$29,162.00
+11.46%
81.06K
Jun 23 - Jun 24
Scheduled
X4 Pharmaceuticals, Inc
8.33K
$7.84
-$32,661.44
+12.94%
72.73K
Jun 15
Scheduled
X4 Pharmaceuticals, Inc
47.73K
—
—
+286.38%
64.39K
Mar 24
X4 Pharmaceuticals, Inc
-8.33K
$8.05
-$67,088.70
-33.34%
16.67K
Sep 9
Scheduled
X4 Pharmaceuticals, Inc
25K
—
—
∞
25K
Aug 14 - Aug 17
X4 Pharmaceuticals, Inc
0
—
—
—
0
Nov 26
X4 Pharmaceuticals, Inc
0
—
—
—
0
Genocea Biosciences, Inc.
0
—
—
—
0
Feb 7
Genocea Biosciences, Inc.
0
—
—
—
0
Sep 20
Genocea Biosciences, Inc.
0
—
—
—
0

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.